Mirna Therapeutics a biotechnology company that specializes in the development of micro-RNA announced in 2013 that Dr. Clay Siegall would be the outside director for the board of directors of Seattle Genetics. Dr. Siegel is also the CEO president and co-founder of the company. My car is a development in the area of cancer research. Dr. Clay Siegel is excited to be a part of the company’s development in micro therapeutic products.
Dr. Siegall co-founded Seattle Genetics in 1998, and they have created many antibody-based therapies to help treat cancer patients. Seattle Genetics has worked together with many world-renowned biomedical and oncology companies to create better strategies, and breakthroughs in the are of cancer research and treatment techniques. His diligent work has helped to develop many alternative treatments for cancer patients that had needs that were not being met through traditional cancer treatment methods. He continues to be on the forefront of research and development in the oncology area.
Dr. Siegall has been involved with many other large corporations in the medical field such as Bristol-Meyers Squib between the years of 1991 until 1997. He worked with the National Institute of Health between 1988 until 1991. He has also collaborated with National Cancer Treatment Centers.
Dr. Seigall is also and inventor and an author. He has authored over 70 publications and held fifteen patents for his inventions. Dr. Clay Siegall earned his bachelor’s in Zoology from the University of Maryland. He received his Ph.D. in the field of Genetics from George Washington University.
Velma Gutierrez August 17, 2016
Posted In: Cancer Research